ZIDAN contains Ranitidine Hydrochloride, a histamine H2-receptor antagonist, as I.M/I.V injectable solution.
ZIDAN is available in the following dosage form:

  • 50mg/2ml ampoule, packs of 5 or 50 ampoules.

ZIDAN is indicated for the treatment of duodenal ulcer, benign gastric ulcer, gastro esophageal reflux disease, persistent dyspepsia, & pathological hypersecretory conditions such as Zollinger-Ellison syndrome.

Download Leaflet: